Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « J. M. Senard »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
J. M. Maloteaux < J. M. Senard < J. Mark Gibson  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000578 (1998) Olivier Rascol [France] ; K. Sieradzan [Royaume-Uni] ; H. Peyro-Saint-Paul [France] ; C. Thalamas [France] ; C. Brefel-Courbon [France] ; J. M. Senard [France] ; P. Ladure [France] ; J. L. Montastruc [France] ; A. Lees [Royaume-Uni]Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy
000618 (1995) Rascol [France] ; U. Sabatini [Italie] ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montastruc [France] ; M. Clanet [France] ; A. Rascol [France]Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease
000624 (1995) Olivier Rascol [France] ; U. Sabatini ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montrastruc [France] ; M. Clanet [France] ; A. Rascol [France]Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease
000628 (1994) J. L. Montastruc [France] ; N. Fabre [France] ; Olivier Rascol [France] ; J. M. Senard [France] ; O. Blin [France]N‐methyl‐D‐aspartate (NMDA) antagonist and Parkinson's disease: A pilot study with dextromethorphan

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Aged
2Humans
2Middle Aged
2Multiple system atrophy
2Parkinson Disease (physiopathology)
1Adult
1Age Factors
1Agonist
1Atrophy (diagnosis)
1Atrophy (physiopathology)
1Brain (pathology)
1Cerebral Palsy (diagnosis)
1Cerebral Palsy (physiopathology)
1Chemotherapy
1Comparative study
1Crossover study
1Dextromethorphan (administration & dosage)
1Dextromethorphan (adverse effects)
1Diagnosis, Differential
1Dose-Response Relationship, Drug
1Double blind study
1Drug Administration Schedule
1Drug Therapy, Combination
1Efaroxan
1Exploration
1Female
1Human
1Levodopa (administration & dosage)
1Levodopa (adverse effects)
1Male
1Motricity
1N-Methylaspartate (antagonists & inhibitors)
1N-Methylaspartate (physiology)
1Neurologic Examination (drug effects)
1Parkinson Disease (diagnosis)
1Parkinson Disease (drug therapy)
1Parkinson disease
1Parkinson's disease
1Progressive
1Randomization
1Receptors, N-Methyl-D-Aspartate (drug effects)
1Receptors, N-Methyl-D-Aspartate (physiology)
1Reflex, Vestibulo-Ocular
1Supranuclear ophthalmoplegia
1Supranuclear palsy
1Supranuclear paralysis
1Treatment
1Vestibuloocular reflex
1Vestibuloocular reflex cancellation
1α2-Adrenergic receptor

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "J. M. Senard" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "J. M. Senard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    J. M. Senard
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024